SCHEMBL14256700

SCHEMBL14256700

OCc1ccccc1Sc1ccccc1CNc1nc(NC2CCOCC2)c2ccccc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 2/20 0.46
▸ BCHE P06276 2/20 0.46
▸ ACHE P22303 2/20 0.46
▸ MERTK Q12866 6/20 0.43
▸ BCDIN3D Q7Z5W3 1/20 0.42
▸ MAOB P27338 2/20 0.41
▸ HTR6 P50406 2/20 0.41
▸ WHR1 P49842 1/20 0.41
▸ CXCR4 P61073 1/20 0.40
▸ KDM1A O60341 1/20 0.40
▸ EHMT2 Q96KQ7 1/20 0.40
▸ ACP1 P24666 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ RAD52 P43351 1/20 0.39
▸ NPY5R Q15761 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14256444 0.91 MERTK (0.53) APPBCHEACHEMERTKWHR1
SCHEMBL14256699 0.90 MERTK (0.52) APPBCHEACHEMERTKCXCR4
SCHEMBL14412272 0.88 CXCR4 (0.52) APPBCHEACHEMERTKWHR1
SCHEMBL14412234 0.86 GBA1 (0.49) APPBCHEACHEMERTKALDH1A1
SCHEMBL14412248 0.85 APP (0.45) APPBCHEACHEMERTKWHR1
SCHEMBL14412253 0.83 PDE5A (0.45) APPBCHEACHEMERTKWHR1
SCHEMBL14256671 0.83 APP (0.41) APPBCHEACHEMERTKWHR1
SCHEMBL14256741 0.82 WHR1 (0.45) APPBCHEACHEMERTKWHR1
SCHEMBL14412252 0.82 APP (0.40) APPBCHEACHEMERTKWHR1
SCHEMBL14256643 0.82 PDE5A (0.41) ACHEACP1ALDH1A1ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2008-03-06 — — US disclosed
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2008-03-06 — — US disclosed
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2007-09-13 — — US disclosed
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2007-09-13 — — US disclosed
WO-2007081978-A2 MODULATORS OF HEPATOCYTE GROWTH FACTOR / C-MET ACTIVITY ANGION BIOMEDICA CORPORATION (US) 2007-07-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity HGF, MET, HDGF APP 3034/4885BCHE 2084/4885ACHE 3271/4885
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity HGF, MET, HDGF APP 2885/4885BCHE 2227/4885ACHE 3315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback